merit medical systems

Piper Jaffray is out with its report today on Merit Medical Systems (NASDAQ: MMSI), reiterating Overweight. In a note to clients, Piper Jaffray writes, "Merit reported a strong Q1 with both revenues and adjusted EPS coming in ahead of our thinking. Core business revenues were up 17%. The recently...

Duncan-Williams is out with its report today on Merit Medical Systems (NASDAQ: MMSI), maintaining Hold. In a note to clients, Duncan-Williams writes, "We are maintaining our HOLD rating on MMSI based on valuation as MMSI is trading at 21 times our 2011 adjusted EPS estimate of $1.00. This is in...

Piper Jaffray is out with its report today on Merit Medical Systems (NASDAQ: MMSI), raising its price target from $20 to $24. In a note to clients, Piper Jaffray writes, "Merit reported robust Q4 results with both sales and adjusted EPS coming in ahead of our thinking. In addition, management...

Piper Jaffray has raised the price target on Merit Medical Systems (NASDAQ: MMSI) from $20 to $24 and maintains its Overweight rating.